Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 10, 2000

Primary Completion Date

January 24, 2014

Study Completion Date

January 24, 2014

Conditions
TumorsMalignant MelanomaHematological MalignanciesMyelogenous Leukemia, ChronicLeukemia, Lymphoblastic, Acute
Interventions
PROCEDURE

Immunoablative Hematopoietic PBSC Transplant

Immunoablative conditioning chemotherapy regimen, followed by transplantation of peripheral blood stem cells on Day 0 of the conditioning regimen.

PROCEDURE

Busulfan pharmacokinetics

Pharmacokinetics of once-a-day dosing of intravenous busulfan as a 3-hour infusion

RADIATION

Central Nervous System (CNS) prophylaxis radiation

"* Patients diagnosed with ALL over 1 year of age and without prior CNS disease will receive CNS prophylaxis radiation to the whole brain prior to transplant.~* Patients diagnosed with ALL with prior CNS disease over the age of 1 year will be treated with prophylaxis radiation to the whole brain and spine prior to transplant."

Trial Locations (1)

60611

Lurie Children's Hospital, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT00179764 - Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) | Biotech Hunter | Biotech Hunter